Establishment of a High-risk MDS/AML Cell Line YCU-AML1 and its Xenograft Model Harboring t(3;3) and Monosomy 7

Acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) with both inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and monosomy 7 defines an extremely aggressive myeloid cancer whose molecular pathogenesis and optimal therapeutic strategy still remain unclear. We established a new MDS/AML cell line, YCU-A...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunimoto, Hiroyoshi, Fukuchi, Yumi, Murakami, Koichi, Ikeda, Junji, Teranaka, Hiroshi, Kato, Ikuma, Miyazaki, Takuya, Enaka, Makiko, Mitsuhashi, Takayuki, Yamazaki, Etsuko, Kameyama, Kaori, Murata, Mitsuru, Okamoto, Shinichiro, Nakajima, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643909/
https://www.ncbi.nlm.nih.gov/pubmed/33163905
http://dx.doi.org/10.1097/HS9.0000000000000469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643909/
https://www.ncbi.nlm.nih.gov/pubmed/33163905
http://dx.doi.org/10.1097/HS9.0000000000000469

Ejemplares similares